Cargando…
Blockade of glucagon signaling prevents or reverses diabetes onset only if residual β-cells persist
Glucagon secretion dysregulation in diabetes fosters hyperglycemia. Recent studies report that mice lacking glucagon receptor (Gcgr(-/-)) do not develop diabetes following streptozotocin (STZ)-mediated ablation of insulin-producing β-cells. Here, we show that diabetes prevention in STZ-treated Gcgr(...
Autores principales: | Damond, Nicolas, Thorel, Fabrizio, Moyers, Julie S, Charron, Maureen J, Vuguin, Patricia M, Powers, Alvin C, Herrera, Pedro L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4871705/ https://www.ncbi.nlm.nih.gov/pubmed/27092792 http://dx.doi.org/10.7554/eLife.13828 |
Ejemplares similares
-
Normal Glucagon Signaling and β-Cell Function After Near-Total α-Cell Ablation in Adult Mice
por: Thorel, Fabrizio, et al.
Publicado: (2011) -
Liver-Specific Disruption of the Murine Glucagon Receptor Produces α-Cell Hyperplasia: Evidence for a Circulating α-Cell Growth Factor
por: Longuet, Christine, et al.
Publicado: (2013) -
Insulin and Glucagon: Partners for Life
por: Holst, Jens Juul, et al.
Publicado: (2017) -
Hepatic Glucagon Action Is Essential for Exercise-Induced Reversal of Mouse Fatty Liver
por: Berglund, Eric D., et al.
Publicado: (2011) -
Oxyntomodulin increases intrinsic heart rate through the glucagon receptor
por: Mukharji, Auyon, et al.
Publicado: (2013)